Register entry

URONOVA PHARMACEUTICALS, INC.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
4
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 human prescription drug. By marketing category: NDA AUTHORIZED GENERIC 4.

Dosage formNDCs
injection, suspension, extended release4
RouteNDCs
subcutaneous4
Labeller name on the listingNDCs
uronova pharmaceuticals, inc.4
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
VabrintyLeuprolide acetateinjection, suspension, extended release, subcutaneous85043-025NDA AUTHORIZED GENERIC
VabrintyLeuprolide acetateinjection, suspension, extended release, subcutaneous85043-030NDA AUTHORIZED GENERIC
VabrintyLeuprolide acetateinjection, suspension, extended release, subcutaneous85043-045NDA AUTHORIZED GENERIC
VabrintyLeuprolide acetateinjection, suspension, extended release, subcutaneous85043-075NDA AUTHORIZED GENERIC
Compare

Other companies listing leuprolide acetate

Enquiry

Common questions

Is URONOVA PHARMACEUTICALS, INC. FDA approved?
URONOVA PHARMACEUTICALS, INC. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does URONOVA PHARMACEUTICALS, INC. make?
4 products are listed under URONOVA PHARMACEUTICALS, INC. in the openFDA NDC Directory, most often as injection, suspension, extended release. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.